Why the study?
Is endothelial lipase expression associated with plaque instability and symptoms in patients with advanced human carotid artery plaques?
Is endothelial lipase expression associated with plaque instability and symptoms in patients with advanced human carotid artery plaques?
Endothelial lipase expression is significantly higher in unstable and symptomatic carotid plaques, suggesting it may serve as a marker or promoter of plaque instability.
May flag unstable symptomatic carotid plaques; leaves open causal role and utility for risk stratification.
The aim of this study was to evaluate endothelial lipase (EL) protein expression in advanced human carotid artery plaques (HCAP) with regard to plaque (in)stability and the incidence of symptoms. HCAP were collected from 66 patients undergoing carotid endarterectomy (CEA). The degree of plaque (in)stability was estimated by ultrasound and histology. In HCAP sections, EL expression was determined by immunostaining and the intensity was assessed on a semi-quantitative scale (low: <25%, high: >25% positive cells). Monocytes and macrophages in adjacent HCAP sections were stained with a CD163 specific antibody. High EL staining was more prevalent in histologically unstable plaques (in 33.3% of fibrous plaques, 50% of ulcerated non-complicated plaques and 79.2% of ulcerated complicated plaques; χ(2) test, p = 0.004) and in the symptomatic group (70.8 vs. 42.9% in the asymptomatic group; χ(2) test, p = 0.028). The majority of EL immunostaining was found in those HCAP regions exhibiting a strong CD163 immunostaining. EL in HCAP might be a marker and/or promoter of plaque instability and HCAP-related symptomatology.
No takes yet. Share an insight, caveat, or question.
Trbušić et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: